TY - JOUR
T1 - Outcomes and temporal trends of inpatient percutaneous coronary intervention at centers with and without on-site cardiac surgery in the United States
AU - Goel, Kashish
AU - Gupta, Tanush
AU - Kolte, Dhaval
AU - Khera, Sahil
AU - Fonarow, Gregg C.
AU - Bhatt, Deepak L.
AU - Singh, Mandeep
AU - Rihal, Charanjit S.
N1 - Funding Information:
completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bhatt is a member of the advisory boards of Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, and Regado Biosciences; a member of the board of directors of Boston Veterans Affairs Research Institute, Society of Cardiovascular Patient Care; chair of the American Heart Association Quality Oversight Committee; a member of data monitoring committees for the Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic, and Population Health Research Institute; has received honoraria from the American College of Cardiology as senior associate editor of Clinical Trials and News, Belvoir Publications as editor in chief of Harvard Heart Letter, Duke Clinical Research Institute as a member of clinical trial steering committees, Harvard Clinical Research Institute as a member of the clinical trial steering committee, HMP Communications as editor in chief of Journal of Invasive Cardiology, Journal of the American College of Cardiology as a guest editor and associate editor, Population Health Research Institute as a member of the clinical trial steering committee, Slack Publications as chief medical editor of Cardiology Today’s Intervention, the Society of Cardiovascular Patient Care as secretary/treasurer, and WebMD as a member of the continuing medical education steering committees. He also reported being deputy editor of Clinical Cardiology and chair of the NCDR-ACTION (National Cardiovascular Database Registry–Acute Coronary Treatment and Intervention Outcomes Network) Registry Steering Committee and the VA CART (Veterans Affairs Cardiovascular Assessment, Reporting, and Tracking) Research and Publications Committee; receiving research funding from Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Forest Laboratories, Ischemix, Medtronic, Pfizer, Roche, Sanofi, and The Medicines Company; receiving royalties from Elsevier; serving as a site co-investigator for Biotronik, Boston Scientific, and St Jude Medical; serving as a trustee of the American College of Cardiology; and performing unfunded research for FlowCo, PLx Pharma, and Takeda. No other disclosures were reported.
Publisher Copyright:
Copyright 2017 American Medical Association. All rights reserved.
PY - 2017/1
Y1 - 2017/1
N2 - IMPORTANCE: There are concerns whether percutaneous coronary intervention (PCI) at centers without on-site cardiac surgery is safe outside of a tightly regulated research environment. OBJECTIVE: To analyze the outcomes and temporal trends of inpatient PCI at centers without on-site cardiac surgery in an unselected and nationally representative population of the United States. DESIGN, SETTING, AND PARTICIPANTS: A national inpatient sample (N = 6 912 232) was used to identify patients who underwent inpatient PCI in the United States from January 1, 2003, to December 31, 2012. Hospitals that performed 1 or more coronary artery bypass graft surgeries in a given calendar year were classified as centers with on-site cardiac surgery, and weighted sampling of all inpatient hospitalizations was performed. Data analysis was performed from February to May 2016. EXPOSURES: Inpatient PCI. MAIN OUTCOMES AND MEASURES: In-hospital mortality. RESULTS: Of the 6 912 232 inpatient PCIs performed, 2 336 334 patients (33.8%) were women and 4 575 898 (66.2%) were men; their mean (SD) age was 64.5 (12.3) years. Of these PCIs, 396 741 (5.7%) were conducted at centers without on-site cardiac surgery. The rate of in-hospital mortality was significantly lower at centers with on-site cardiac surgery compared with centers without on-site cardiac surgery (1.4% vs 1.9%; unadjusted odds ratio [OR], 0.74; 95% CI, 0.72-0.75). After adjustment, there was no significant difference in in-hospital mortality between centers with and without on-site cardiac surgery (OR, 1.01; 95% CI, 0.98-1.03; P = .62) for acute coronary syndromes and elective procedures requiring inpatient hospitalization. In addition, there were no significant differences in the risk-adjusted, in-hospital mortality between the 2 groups in prespecified subgroups after adjusting for multiple comparisons, including ST-elevation myocardial infarction (OR, 0.99; 95% CI, 0.96-1.03; P = .65), non-ST-elevation acute coronary syndrome (OR, 0.99; 95% CI, 0.93-1.05; P = .66), and elective PCI (OR, 0.93; 95% CI, 0.84-1.03; P = .17). There was a significant increase in the proportion of PCIs at centers without on-site cardiac surgery within the study period (from 1.8% to 12.7%; P < .001 for trend by Cochrane-Armitage test) reflected across all the indications. CONCLUSIONS AND RELEVANCE: There was a 7-fold increase in the proportion of PCIs at centers without on-site cardiac surgery from 2003 to 2012 in the United States, with the adjusted in-hospital mortality after inpatient PCI being similar at centers with and without on-site cardiac surgery. These data provide evidence that PCI at centers without on-site cardiac surgery may be safe in the modern era.
AB - IMPORTANCE: There are concerns whether percutaneous coronary intervention (PCI) at centers without on-site cardiac surgery is safe outside of a tightly regulated research environment. OBJECTIVE: To analyze the outcomes and temporal trends of inpatient PCI at centers without on-site cardiac surgery in an unselected and nationally representative population of the United States. DESIGN, SETTING, AND PARTICIPANTS: A national inpatient sample (N = 6 912 232) was used to identify patients who underwent inpatient PCI in the United States from January 1, 2003, to December 31, 2012. Hospitals that performed 1 or more coronary artery bypass graft surgeries in a given calendar year were classified as centers with on-site cardiac surgery, and weighted sampling of all inpatient hospitalizations was performed. Data analysis was performed from February to May 2016. EXPOSURES: Inpatient PCI. MAIN OUTCOMES AND MEASURES: In-hospital mortality. RESULTS: Of the 6 912 232 inpatient PCIs performed, 2 336 334 patients (33.8%) were women and 4 575 898 (66.2%) were men; their mean (SD) age was 64.5 (12.3) years. Of these PCIs, 396 741 (5.7%) were conducted at centers without on-site cardiac surgery. The rate of in-hospital mortality was significantly lower at centers with on-site cardiac surgery compared with centers without on-site cardiac surgery (1.4% vs 1.9%; unadjusted odds ratio [OR], 0.74; 95% CI, 0.72-0.75). After adjustment, there was no significant difference in in-hospital mortality between centers with and without on-site cardiac surgery (OR, 1.01; 95% CI, 0.98-1.03; P = .62) for acute coronary syndromes and elective procedures requiring inpatient hospitalization. In addition, there were no significant differences in the risk-adjusted, in-hospital mortality between the 2 groups in prespecified subgroups after adjusting for multiple comparisons, including ST-elevation myocardial infarction (OR, 0.99; 95% CI, 0.96-1.03; P = .65), non-ST-elevation acute coronary syndrome (OR, 0.99; 95% CI, 0.93-1.05; P = .66), and elective PCI (OR, 0.93; 95% CI, 0.84-1.03; P = .17). There was a significant increase in the proportion of PCIs at centers without on-site cardiac surgery within the study period (from 1.8% to 12.7%; P < .001 for trend by Cochrane-Armitage test) reflected across all the indications. CONCLUSIONS AND RELEVANCE: There was a 7-fold increase in the proportion of PCIs at centers without on-site cardiac surgery from 2003 to 2012 in the United States, with the adjusted in-hospital mortality after inpatient PCI being similar at centers with and without on-site cardiac surgery. These data provide evidence that PCI at centers without on-site cardiac surgery may be safe in the modern era.
UR - http://www.scopus.com/inward/record.url?scp=85017733411&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85017733411&partnerID=8YFLogxK
U2 - 10.1001/jamacardio.2016.4188
DO - 10.1001/jamacardio.2016.4188
M3 - Article
C2 - 27893054
AN - SCOPUS:85017733411
SN - 2380-6583
VL - 2
SP - 25
EP - 33
JO - JAMA cardiology
JF - JAMA cardiology
IS - 1
ER -